← Back to directory
G
Gimv
Antwerp, BelgiumWebsite ↗
Gimv is a publicly listed European investment company with over 40 years of experience in private equity and venture capital, partnering with entrepreneurial and innovative companies to support their sustainable growth and transformation into market leaders. The firm primarily invests directly from its balance sheet, acting as an evergreen partner with a long-term vision.
Last raised
Feb 2013
13y 8mo ago
Latest fund size
$108M
Health & Care Fund
AUM
$2.4B
estimated
Funds raised
Capital this firm has raised, newest first
Health & Care Fund
Feb 2013
$108M
Gimv XL
Jan 2009
—
Gimv-Agri+
Jan 2009
—
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Soins Modernes des Arbres | — | — | Jun 2026 | |
| 3Point | — | — | Jun 2026 | |
| Kooklin | — | — | Jun 2026 | |
| Azelis | — | — | Apr 2026 | |
| ExcivaLead | Series B | $60.6M | Jan 2026 | |
| Kinaset Therapeutics | Series B | $103M | Jan 2026 | |
| Quality Guard | — | — | Nov 2025 | |
| Spineart | Series B | — | Sep 2025 |
Sources
Where this data came from